VectivBio Holding AG announced its initial public offering and listing of its shares on Nasdaq (ticker symbol VECT). VectivBio is a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of innovative treatments for severe rare conditions for
Homburger acted as counsel to FONPLATA. The team consisted of partner René Bösch (Capital Markets), counsel Eduard De Zordi (Capital Markets) and associate Sofiya Shavlak (Capital Markets).
Walder Wyss acted as counsel to Credit Suisse and UBS as Joint Global Coordinators and Joint Bookrunners in the Rights Offering of Swiss Steel Holding (read here all the advisors).
The Pestalozzi team included Christian Leuenberger (Lead Partner - Capital Markets, Corporate/M&A - pictured), Severin Roelli (Partner - Corpoarte/M&A), Manu Ferro (Associate - Banking & Finance).
NKF acted as legal counsel to Swiss Steel Holding in the capital increase and all related proceedings before the courts, FINMA and the Swiss Takeover Board. The NKF team was led by Corporate and Capital Markets partner Philippe Weber (pictured)